Suppiramaniam, Vishnu

Amyloid beta peptides and glutamatergic synaptic dysregulation

Parameshwaran, K., Dhanasekaran, M., & Suppiramaniam, V. (2008) · Experimental Neurology

Alzheimer's disease research and treatmentsNeuroscience and Neuropharmacology Research

Cited by 235

Gut Metabolite TMAO Induces Synaptic Plasticity Deficits by Promoting Endoplasmic Reticulum Stress

Govindarajulu, M., Pinky, P. D., Steinke, I., Bloemer, J., Ramesh, S., Kariharan, T., Rella, R. T., Bhattacharya, S., Dhanasekaran, M., Suppiramaniam, V., et al. (2020) · Frontiers in Molecular Neuroscience

Alzheimer's disease research and treatmentsNeuroscience and Neuropharmacology Research

Cited by 113

The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions

Hunsberger, H. C., Pinky, P. D., Smith, W., Suppiramaniam, V., & Reed, M. N. (2019) · Neuronal Signaling

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 94

Protective effects of tauroursodeoxycholic acid on lipopolysaccharide-induced cognitive impairment and neurotoxicity in mice

Wu, X., Liu, C., Chen, L., Du, Y.-F., Hu, M., Reed, M. N., Long, Y., Suppiramaniam, V., Hong, H., & Tang, S.-S. (2019) · International Immunopharmacology

Neuroinflammation and Neurodegeneration MechanismsNeurological Disease Mechanisms and Treatments

Cited by 56